MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.

Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic...

Bibliografske podrobnosti
Main Authors:	Allahabadia, A, Heward, J, Nithiyananthan, R, Gibson, S, Reuser, T, Dodson, P, Franklyn, J, Gough, S
Format:	Journal article
Jezik:	English
Izdano:	2001

Podobne knjige/članki

Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
od: Nithiyananthan, R, et al.
Izdano: (2002)

No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom.
od: Heward, J, et al.
Izdano: (2001)

The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
od: Heward, J, et al.
Izdano: (1999)

Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.
od: Syed, A, et al.
Izdano: (2007)

The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus.
od: Heward, J, et al.
Izdano: (1999)

Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK.
od: Tait, K, et al.
Izdano: (2004)

A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association.
od: Nithiyananthan, R, et al.
Izdano: (2000)

Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians.
od: Collins, J, et al.
Izdano: (2004)

Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
od: Heward, J, et al.
Izdano: (1998)

Associations of CTLA4 Gene Polymorphisms with Graves’ Ophthalmopathy: A Meta-Analysis
od: Pengfei Du, et al.
Izdano: (2014-01-01)

Sharing of susceptibility loci between autoimmune diseases: lack of association of the insulin gene region with Graves' disease.
od: Allahabadia, A, et al.
Izdano: (1999)

A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease.
od: Simmonds, M, et al.
Izdano: (2004)

Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease.
od: Zeitlin, A, et al.
Izdano: (2008)

Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.
od: Heward, J, et al.
Izdano: (1999)

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
od: Harper, L, et al.
Izdano: (2004)

Association of CTLA4 and TNF gene polymorphisms with endocrine ophthalmopathy in ethnic Russian patients with Graves’ disease
od: N S Martirosian, et al.
Izdano: (2015-10-01)

Graves' ophthalmopathy
od: Swiss Medical Weekly
Izdano: (2002-01-01)

IL-13 and chromosome 5q31-q33: problems of identifying association within regions of linkage to Graves' disease.
od: Simmonds, M, et al.
Izdano: (2005)

A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al.
od: Simmonds, M, et al.
Izdano: (2002)

No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
od: Heward, J, et al.
Izdano: (1998)

The CD40 Kozak SNP: a new susceptibility loci for Graves' disease?
od: Simmonds, M, et al.
Izdano: (2005)

Autophagy in graves’ ophthalmopathy
od: Yu-Qing Chen, et al.
Izdano: (2023-04-01)

Treatment of Graves' ophthalmopathy
Izdano: (2010-09-01)

Age and gender predict the outcome of treatment for Graves' hyperthyroidism.
od: Allahabadia, A, et al.
Izdano: (2000)

Association of PTPN22 haplotypes with Graves' disease.
od: Heward, J, et al.
Izdano: (2007)

Psychological aspects of Graves’ ophthalmopathy
od: Waleed K W Al-Badri, et al.
Izdano: (2024-08-01)

Graves' ophthalmopathy: interdisciplinary approach
Izdano: (2010-12-01)

Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies.
od: Allahabadia, A, et al.
Izdano: (1998)

HLA , CTLA-4 and PTPN22 : the shared genetic master-key to autoimmunity?
od: Brand, O, et al.
Izdano: (2005)

The Influence of Juvenile Graves’ Ophthalmopathy on Graves’ Disease Course
od: Jurate Jankauskiene, et al.
Izdano: (2017-01-01)

Tag SNP screening of the PDCD1 gene for association with Graves' disease.
od: Newby, P, et al.
Izdano: (2007)

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.
od: Brand, O, et al.
Izdano: (2007)

The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases.
od: Heward, J, et al.
Izdano: (1999)

Regression mapping of association between the human leukocyte antigen region and Graves disease.
od: Simmonds, M, et al.
Izdano: (2005)

Endoscopic Orbital Decompression for Graves’ Ophthalmopathy
od: Tang, Ing Ping, et al.
Izdano: (2008)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
od: Larysa Krajewska-Węglewicz, et al.
Izdano: (2018-12-01)

Treatment of ophthalmopathy in the course of Graves’ disease
od: Magdalena Woźniak, et al.
Izdano: (2019-09-01)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
od: Irini P. Chatziralli, et al.
Izdano: (2010-09-01)

Graves’ ophthalmopathy – thyroid eye disease
od: Dagna Siedlecka, et al.
Izdano: (2019-08-01)

Treatment of ophthalmopathy in the course of Graves’ disease
od: Magdalena Woźniak, et al.
Izdano: (2019-09-01)